# Comprehensive Blood & Cancer Center

> Comprehensive Blood & Cancer Center is a VC fund backing Health Care and Information Technology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Bakersfield, United States
- Total investments: 2
- Last investment: May 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/comprehensive-blood-and-cancer-center/
- X (Twitter): https://twitter.com/cbccusa
- Website: https://cbccusa.com
- Facebook: https://www.facebook.com/ComprehensiveBloodandCancerCenterBakerfield

Comprehensive Blood & Cancer Center is a VC fund in Bakersfield focused on Health Care and Information Technology. Comprehensive Blood & Cancer Center specializes in surgical oncology, hematology, radiation oncology, skin, and dermatology.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Information Technology | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Akido Labs | Akido is a care delivery platform focused on overcoming the complex needs of our most vulnerable populations. We are on a mission to leverage modern technology and proprietary datasets that have historically been locked up in our public health ecosystems in order to radically improve the quality of life and affordability of care for underservedpeople.We are a fast-growing, impact-focused, Y Combinator company being used nationwide to combat the Covid-19 pandemic, homelessness, and other public health crises. Across the country, health systems and government service providers use Akido to launch new technology-powered public health initiatives that improve the health and well-being of the communities they serve. | $60M | Series B | May 15, 2025 |  |
| Akido Labs | Akido is a care delivery platform focused on overcoming the complex needs of our most vulnerable populations. We are on a mission to leverage modern technology and proprietary datasets that have historically been locked up in our public health ecosystems in order to radically improve the quality of life and affordability of care for underservedpeople.We are a fast-growing, impact-focused, Y Combinator company being used nationwide to combat the Covid-19 pandemic, homelessness, and other public health crises. Across the country, health systems and government service providers use Akido to launch new technology-powered public health initiatives that improve the health and well-being of the communities they serve. | $11.2M | Series A | Dec 16, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [Future Communities Capital](https://shizune.co/investors/profile/future-communities-capital) — VC Fund, 2 deals together
- [Y Combinator](https://shizune.co/investors/profile/y-combinator) — VC Fund, 2 deals together
- [Great Oaks Venture Capital](https://shizune.co/investors/profile/great-oaks-venture-capital) — VC Fund, 1 deal together
- [GrECo](https://shizune.co/investors/profile/greco-bc66) — VC Fund, 1 deal together
- [Mentors Fund](https://shizune.co/investors/profile/mentors-fund) — VC Fund, 1 deal together
- [Mission and Market](https://shizune.co/investors/profile/mission-and-market) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Comprehensive Blood & Cancer Center invest in?

Comprehensive Blood & Cancer Center invests primarily in Health Care and Information Technology startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Comprehensive Blood & Cancer Center last invest?

The most recent investment recorded for Comprehensive Blood & Cancer Center closed in May 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co